Bone loss following hematopoietic stem cell transplantation: A long-term follow-up

Blood

Volumn 103, Issue 10, 2004, Pages 3635-3643

  Schulte, Claudia M S ^a   Beelen, Dietrich W ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CALCIUM; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IBANDRONIC ACID; METHOTREXATE; PREDNISOLONE; STEROID; VITAMIN D;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; DENSITOMETRY; FEMALE; FEMUR NECK; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PRIORITY JOURNAL; RISK FACTOR; SPINE;

EID: 2342521935     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-09-3081     Document Type: Article

References (42)

1. Cohen A, Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporosis Int. 2003;14:617-630.
2. Kreig MA, Seydoux C, Sandini L, et al. Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study. Osteoporosis Int. 2001;12:112-116.
3. Pichette V, Bonnardeaux A, Prudhomme L, et al. Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study. Am J Kidney Dis. 1996;28:105-114.
4. Leidig-Bruckner G, Hosch S, Dodidou P, et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet. 2001;357:342-347.
5. Spira A, Gutierrez C, Chaparro C, et al. Osteoporosis and lung transplantation: a prospective study. Chest. 2000;117:476-481.
6. Julian BA, Laskow DA, Dubovsky J, et al. Rapid loss of vertebral density after renal transplantation. N Engl J Med. 1991;325:544-550.
7. McDonald JA, Dunstan CR, Dilworth P, et al. Bone loss after liver transplantation. Hepatology. 1991;14:613-619.
8. Horber FF, Casez JP, Steiger U, et al. Changes in bone mass early after kidney transplantation. J Bone Miner Res. 1994;9:1-9.
9. Henderson NK, Sambrook PN, Kelly PJ. Bone mineral loss and recovery after cardiac transplantation. Lancet. 1995;2:905.
10. Gandhi MK, Lekamwasam S, Inman I, et al. Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study. Br J Haematol. 2003;121:462-468.
11. Ebeling PR, Thomas DM, Erbas B, et al. Mechanisms of bone loss following allogeneic and autologous hematopoetic stem cell transplantation. J Bone Miner Res. 1999;14:342-350.
12. Schulte C, Beelen DW, Schaefer UW, et al. Bone loss in long-term survivors after transplantation of haematopoietic stem cells: a prospective study. Osteoporos Int. 2000;11:344-353.
13. Lee WY, Kang MI, Baek KH, et al. The skeletal site-differential changes in bone mineral density following bone marrow transplantation: 3-year prospective study. J Korean Med Sci. 2002;17: 749-754.
14. Carlo-Stella C, Tabilio A, Regazzi E, et al. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant. 1997;20:465-471.
15. Banfi A, Podesta M, Fazzuoli L, et al. High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia. Cancer. 2001;92:2419-2428.
16. Takahashi S, Sugimoto M, Kotoura, Y, et al. Long-term changes in the haversian systems following high-dose irradiation: an ultrastructural and quantitative histomorphological study. J Bone Joint Surg Am. 1994;76:722-738.
17. Katz IA, Epstein S. Perspectives: posttransplantation bone disease. J Bone Miner Res. 1992;7: 123-126.
18. Kauppila M, Irjala K, Koskinen P, et al. Bone mineral density after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1999;24: 885-889.
19. Keilholz U, Max R, Scheibenbogen C, et al. Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation. Cancer. 1997;79: 1617-1622.
20. Stern JM, Sullivan KM, Ott SM, et al. Bone density after allogeneic hematopoetic stem cell transplantation: a prospective study. Biol Blood Marrow Transplant. 2001;7:257-264.
21. Valimaki MJ, Kimmunen K, Volin L, et al. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant. 1999;23:355-361.
22. Kananen K, Volin L, Tahtela R, et al. Recovery of bone mass and normalization of bono turnover in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant. 2002; 29:33-39.
23. Schimmer AD, Mah K, Bordeleau L, et al. Decreased bone mineral density is common after autologous blood or marrow transplantation. Bone Marrow Transplant. 2001;28:387-391.
24. Goldman JM. Chronic myeloid leukemia. Curr Opin Hematol. 1997;4:277-285.
25. Savage DG, Goldman JM. Allografting for chronic myeloid leukemia. Curr Opin Hematol. 1997;4: 369-376.
26. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998;339:605-615.
27. Pawson R, Mufti GJ, Pagliuca A. Management of adult T-cell leukemia/lymphoma. Br J Haematol. 1998;100:453-458.
28. Davis TA, Homing SJ. Advances in the management of Hodgkin's and non-Hodgkin's lymphoma. Curr Opin Hematol. 1998;5:259-263.
29. Beelen DW, Graeven U, Elmaagacli AH, et al. Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome. Blood. 1995;85:2981-2990.
30. Klingebiel T, Schlegel PG. GVHD: overview on pathophysiology, incidence, clinical and biological features. Bone Marrow Transplant. 1998;21:S45-S49.
31. Schaefer UW, Beelen DW. Bone marrow transplantation. In: Schaefer UW, Beelen DW, eds. 2nd ed. Freiburg, Germany: Karger Publishers; 1996.
32. Atkinson K, Horowitz MM, Gale RP, et al. Consensus among bone marrow transplanters for diagnosis grading and treatment of chronic graft-versus host disease: Committee of the International Bone Marrow Transplant Registry. Bone Marrow Transplant. 1989;4:247-254.
33. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295-304.
34. Kanis JA, Gluer C-C. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporosis Int. 2000;11:192-202.
35. Buchs N, Helg C, Collao C, et al. Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss. Osteoporosis Int. 2001;12:880-886.
36. Schimmer AD, Minden MD, Keating A. Osteoporosis after blood and marrow transplantation: clinical aspects. Biol Blood Marrow Transplant. 2000;6:175-181.
37. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J. 1996;312:1254-1259.
38. Lunt M, Felsenberg D, Reeve J, et al. Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS Study. J Bone Miner Res. 1997;12:1883-1894.
39. Nguyen T, Sambrook P, Kelly P, et al. Prediction of osteoporotic fractures by postural instability and bone density. Br Med J. 1993;307:1111-1115.
40. Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA. 2001;285:320-323.
41. Nuzzo S, Lafage-Proust MH, Martin-Badosa E, et al. Synchrotron radiation micro-tomography allows the analysis of three-dimensional architecture and degree of mineralization of human iliac crest biopsy specimens: effect of etidronate treatment. J Bone Miner Res. 2002;17:1372-1382.
42. Link TM, Bauer JS. Imaging of trabecular bone structure. Semin Musculoskelet Radiol. 2002; 6:253-261.